MetLife, Inc. Website

MetLife, Inc.

NYSE-MET

Basic

  • Market Cap

    $52.19B

  • EV

    $73.1B

  • Shares Out

    711.12M

  • Revenue

    $67.57B

  • Employees

    45,000

Margins

  • Gross

    23.41%

  • EBITDA

    6.98%

  • Operating

    5.92%

  • Pre-Tax

    4.37%

  • Net

    3.5%

  • FCF

    20.75%

Returns (5Yr Avg)

  • ROA

    0.7%

  • ROTA

    16.64%

  • ROE

    9.17%

  • ROCE

    1.06%

  • ROIC

    0.83%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $82.41

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $19.84B

  • Net Debt

    $20.65B

  • Debt/Equity

    1.41

  • EBIT/Interest

    3.79

Growth (CAGR)

  • Rev 3Yr

    1.25%

  • Rev 5Yr

    -0.54%

  • Rev 10Yr

    -0.11%

  • Dil EPS 3Yr

    33.08%

  • Dil EPS 5Yr

    -10.79%

  • Dil EPS 10Yr

    -0.98%

  • Rev Fwd 2Yr

    3.24%

  • EBITDA Fwd 2Yr

    -6.48%

  • EPS Fwd 2Yr

    15.57%

  • EPS LT Growth Est

    13.5%

Dividends

  • Yield

  • Payout

    71.51%

  • DPS

    $2.08

  • DPS Growth 3Yr

    4.17%

  • DPS Growth 5Yr

    4.36%

  • DPS Growth 10Yr

    6.58%

  • DPS Growth Fwd 2Yr

    4.42%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Premiums and Annuity Revenues

47,838

47,637

46,396

53,735

49,435

49,858

Total Interest And Dividend Income

17,959

16,048

21,326

15,852

19,858

20,370

Gain (Loss) on Sale of Investments, Total

469

-115

1,596

-1,065

-2,727

-2,446

Other Revenues, Total

3,354

4,272

-630

242

335

-212

Total Revenues

69,620

67,842

68,688

68,764

66,901

67,570

Total Revenues % Chg.

2.5%

-2.6%

1.2%

0.1%

-2.7%

-1.7%

Policy Benefits

49,136

47,765

48,160

50,547

52,033

51,754

Selling General & Admin Expenses, Total

Other Operating Expenses

12,628

12,239

11,100

10,922

11,667

11,817

Total Operating Expenses

61,764

60,004

59,260

61,469

63,700

63,571

Operating Income

7,856

7,838

9,428

7,295

3,201

3,999

Interest Expense, Total

-955

-913

-920

-938

-1,045

-1,054

Currency Exchange Gains (Loss)

2

2

10

7

6

5

EBT, Excl. Unusual Items

6,903

6,927

8,518

6,364

2,162

2,950

Restructuring Charges

-108

Other Unusual Items

EBT, Incl. Unusual Items

6,795

6,927

8,518

6,364

2,162

2,950

Income Tax Expense

886

1,509

1,642

1,062

560

558

Earnings From Continuing Operations

5,909

5,418

6,876

5,302

1,602

2,392

Earnings Of Discontinued Operations

Minority Interest

-10

-11

-21

-18

-24

-27

Net Income

5,899

5,407

6,855

5,284

1,578

2,365

Preferred Dividend and Other Adjustments

178

216

201

185

198

199

Net Income to Common Incl Extra Items

5,721

5,191

6,654

5,099

1,380

2,166

Net Income to Common Excl. Extra Items

5,721

5,191

6,654

5,099

1,380

2,166

Total Shares Outstanding

915.3

892.9

825.5

779.1

730.8

715.7

Weighted Avg. Shares Outstanding

937.6

907.8

862.7

803.2

757.7

744.7

Weighted Avg. Shares Outstanding Dil

944.4

913.2

869.4

808.9

762.3

749.1

EPS

6.1

5.7

7.7

6.3

1.8

2.9

EPS Diluted

6.1

5.7

7.7

6.3

1.8

2.9

EBITDA

8,224

8,250

10,122

7,968

3,919

4,718

Effective Tax Rate

13%

21.8%

19.3%

16.7%

25.9%

18.9%